Ete Group and Soria Natural Partner for Global Natural Medicine Expansion

Ete Group and Soria Natural signed a strategic non-disclosure agreement (NDA) to expand natural medicine distribution in Asia. According to CEONEWS, the partnership focuses on introducing Soria Natural’s CTP raw materials to South Korea and establishing a joint ecosystem for product development and quality control.

Why is Ete Group partnering with Soria Natural?

Ete Group is leveraging Soria Natural’s 40-year history in phytotherapy to meet the rising demand for natural and scientific health supplements in Asia. According to CEONEWS, the collaboration moves beyond simple importing to create a comprehensive ecosystem covering raw material management, joint product development, and shared global distribution networks.

The partnership targets a structural shift in the global health functional food market. CEONEWS reports that post-pandemic consumers are increasingly replacing synthetic ingredients with natural alternatives. This trend aligns with the “K-beauty” and “K-health” movements, which have increased consumer acceptance of high-quality natural products in South Korea.

Did you know? Soria Natural began in 1982 when founder Antonio Esteban Villalobos started harvesting and drying medicinal plants using only two sickles and borrowed capital.

What makes Soria Natural a leader in European phytotherapy?

Soria Natural maintains a competitive edge through a vertically integrated production system. The company operates large-scale proprietary farms using biodynamic farming methods to ensure raw material stability and quality. These materials are then processed in advanced automated facilities, according to CEONEWS.

The company’s scale is significant. CEONEWS reports that Soria Natural employs over 500 specialists, including a research team of more than 30 pharmacists, biologists, and analytical chemists. Their portfolio includes 1,700 product types ranging from medicinal plant extracts and nutritional supplements to organic foods and pet care. Currently, the firm operates distribution networks across 61 countries, with regional offices in Mexico, the U.S., Portugal, and Germany.

Pro Tip: Biodynamic farming, used by Soria Natural, treats the farm as a single self-sustaining organism. This method often results in higher nutrient density in medicinal plants compared to conventional industrial farming.

How will CTP raw materials enter the Asian market?

The central objective of the agreement is the introduction of CTP raw materials to South Korea. CEONEWS describes CTP as a core substance developed independently by Soria Natural over several decades, designed to maintain cellular health and physical balance.

Ete Group Chairman Kim Myung-soo and the founder’s family of Soria Natural met at the company’s botanical garden in Spain to finalize the cooperation direction. Ete Group intends to use its existing distribution channels and branding expertise to maximize the market competitiveness of CTP-based products.

The scope of the NDA includes three primary pillars:

Advanced raw material management to ensure freshness and safety.
Joint development of new products optimized for Asian consumer preferences.
A shared quality system that meets both European and South Korean regulatory standards.

What happens next for the health supplement industry?

Industry analysts are now watching for the transition from this NDA to a formal main contract. The ability of a European infrastructure to merge with Korean marketing agility provides a blueprint for other natural medicine firms seeking entry into the Asian market.

This movement reflects a broader trend where “clean label” products—those with fewer synthetic additives—are dominating growth. By integrating European raw material sourcing with Korean distribution platforms, the partnership addresses the primary bottleneck in the industry: maintaining the potency of natural extracts during long-distance logistics.

Frequently Asked Questions

What is the primary goal of the Ete Group and Soria Natural agreement?
The goal is to improve productivity and expand global market reach, specifically by bringing Soria Natural’s CTP raw materials to the Korean market through a strategic distribution ecosystem.

What is CTP in the context of Soria Natural?
CTP is a proprietary raw material developed by Soria Natural over decades, focused on supporting cellular health and maintaining the body’s internal balance.

Where is Soria Natural based?
The company is based in Garray, in the Castilla y León region of Spain.

Want to stay updated on the intersection of natural medicine and global trade? Share your thoughts in the comments below or subscribe to our newsletter for more industry insights.